dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Serratosa, Joan |
dc.contributor.author | Bove Badell, Jordi |
dc.contributor.author | Vila Bover, Miquel |
dc.contributor.author | Saura, Josep |
dc.contributor.author | Solà, Carme |
dc.contributor.author | Rabaneda-Lombarte, Neus |
dc.date.accessioned | 2021-11-24T09:16:03Z |
dc.date.available | 2021-11-24T09:16:03Z |
dc.date.issued | 2021-04-06 |
dc.identifier.citation | Rabaneda-Lombarte N, Serratosa J, Bové J, Vila M, Saura J, Solà C. The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease. J Neuroinflammation. 2021 Apr 6;18:88. |
dc.identifier.issn | 1742-2094 |
dc.identifier.uri | https://hdl.handle.net/11351/6592 |
dc.description | Micròglia; Neuroinflamació; Malaltia de Parkinson |
dc.description.sponsorship | This study was supported by grant PI15/00033 from the Instituto de Salud Carlos III (Spain) with joint financing by FEDER funds from the European Union. NRL was recipient of a predoctoral contract from the Spanish Ministerio de Educación. Cultura y Deporte FPU (FPU13/05491). |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Journal of Neuroinflammation;18 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Parkinson, Malaltia de - Tractament |
dc.subject | Micròglia - Efecte dels medicaments |
dc.subject.mesh | Microglia |
dc.subject.mesh | /drug effects |
dc.subject.mesh | Parkinson Disease |
dc.subject.mesh | /drug therapy |
dc.title | The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s12974-021-02132-z |
dc.subject.decs | microglía |
dc.subject.decs | /efectos de los fármacos |
dc.subject.decs | enfermedad de Parkinson |
dc.subject.decs | /farmacoterapia |
dc.relation.publishversion | https://doi.org/10.1186/s12974-021-02132-z |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Rabaneda-Lombarte N] Department of Cerebral Ischemia and Neurodegeneration, Institut d’Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas (CSIC), Institut d’Investigacions Biomèdiques August-Pi i Sunyer (IDIBAPS), Barcelona, Spain. Biochemistry and Molecular Biology Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain. [Serratosa J, Solà C] Department of Cerebral Ischemia and Neurodegeneration, Institut d’Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas (CSIC), Institut d’Investigacions Biomèdiques August-Pi i Sunyer (IDIBAPS), Barcelona, Spain. [Bové J] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERNED, Barcelona, Spain. [Vila M] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERNED, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. [Saura J] Biochemistry and Molecular Biology Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain |
dc.identifier.pmid | 33823877 |
dc.identifier.wos | 000637502400001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F00033 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/FPU13%2F05491 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |